Biotech

All Articles

Sanofi's $80M bank on Fulcrum dystrophy medicine finishes in period 3 go under

.Only four months after Sanofi bet $80 thousand in beforehand cash on Pivot Therapies' losmapimod, t...

Oncternal equity drains 60% surrounded by unemployments, test discontinuations

.Cancer cells provider Oncternal Therapeutics is actually folding all its medical tests and laying o...

Roche is holding out hopes that its injectable obesity prospect might ultimately demonstrate 25% effective weight loss in late-stage test

.Roche is actually keeping out hopes that its injectable being overweight prospect can eventually il...

Novo Nordisk barrages 'outstanding' weight management result for dual-acting oral drug in early trial

.Novo Nordisk has actually elevated the top on a stage 1 test of its own oral amylin and GLP-1 recep...

AbbVie sues BeiGene over blood cancer medicine trade secrets

.Simply a couple of brief full weeks after gaining an FDA Fast Track tag for its own investigational...

Lilly supplies one-two hit along with 2nd tranche of beneficial records on regular the hormone insulin prospect

.Not long after a positive information decline for Eli Lilly's efsitora alfa, the Indianapolis-based...

BridgeBio reduces gene therapy finances as scientific information dissatisfy

.BridgeBio Pharma is lowering its own genetics therapy budget plan and also drawing back coming from...

GSK gives up HSV injection hopes after stage 2 stop working, yielding nationality to Moderna, BioNTech

.GSK's attempt to develop the 1st vaccine for herpes simplex virus (HSV) has ended in failure, leavi...

GSK's long-acting bronchial asthma medicine cut in half assaults in phase 3

.GSK's long-acting bronchial asthma treatment has been presented to cut in half the amount of assaul...

AstraZeneca, Daiichi unload Dato-DXd's total survival stop working

.AstraZeneca as well as Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has fallen sho...